Bristol myers squibb co (BMY)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Dec'09Sep'09Jun'09Mar'09
Cash Flows From Operating Activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

979

3,460

5,678

6,224

5,167

4,947

1,460

404

944

975

4,202

4,561

4,827

4,507

3,421

2,936

1,638

1,631

1,846

1,848

2,292

2,029

2,737

2,697

2,893

2,580

2,769

1,364

1,642

2,501

2,808

4,876

5,375

5,260

4,871

4,818

4,779

4,513

12,024

12,012

12,042

11,862

0

0

0

Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Net earnings attributable to noncontrolling interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

17

7

5

174

541

921

1,309

1,551

1,551

1,531

1,498

1,434

1,411

1,380

1,351

1,325

1,250

0

0

0

Depreciation, Depletion and Amortization

4,053

1,746

682

676

664

637

662

685

739

789

714

631

510

382

336

336

337

376

403

410

434

467

545

613

687

763

781

796

755

681

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred Income Tax Expense (Benefit)

-1,055

-924

-381

-5

-37

45

9

395

683

453

579

134

-28

-204

-898

-605

-586

-347

-434

-637

-659

-542

-139

-120

-199

-491

-902

-1,645

-1,616

-1,230

-595

252

442

415

595

568

509

422

84

148

226

163

0

0

0

Share-based Payment Arrangement, Noncash Expense

598

441

210

216

219

221

218

206

209

199

205

203

203

205

208

223

228

235

242

227

218

213

198

195

191

191

186

167

161

154

149

162

165

161

170

178

184

193

196

191

187

183

0

0

0

Impairment of Long-Lived Assets to be Disposed of

207

199

199

196

91

126

214

212

329

327

211

214

122

63

243

240

198

192

39

63

367

401

420

394

84

40

68

1,896

2,085

2,180

2,118

301

111

28

49

43

43

228

0

0

0

-

-

-

-

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

469

484

481

469

0

0

0

Amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

259

257

246

238

0

0

0

Pension settlements and amortization

1,633

1,688

1,724

208

202

186

233

233

234

236

195

193

182

169

189

218

234

245

943

929

941

971

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Divestiture gains and royalties

1,862

1,855

1,846

815

903

992

982

792

685

706

651

671

956

1,187

1,007

1,092

763

490

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Asset acquisition charges

-

-

-

-

-

85

335

645

820

760

510

235

174

274

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Equity investment, (gain) loss

-235

279

-283

75

-352

-512

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from Amylin diabetes alliance

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

1

69

144

135

0

0

0

Other Noncash Income (Expense)

58

22

22

31

36

44

48

18

-73

-120

-145

-99

-7

36

24

142

-26

-15

-524

-309

-220

21

560

195

268

9

67

59

48

35

-12

21

26

147

136

130

133

32

514

460

333

367

0

0

0

Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]
Changes in operating assets and liabilities:
Increase (Decrease) in Receivables

227

-752

-227

234

412

429

114

-135

-34

431

446

405

625

803

1,252

1,527

1,275

942

864

598

450

252

-85

21

79

504

558

300

-438

-648

-575

-652

237

220

300

544

52

270

-182

-237

163

-227

0

0

0

Increase (Decrease) in Inventories

-1,876

-463

71

66

177

216

188

93

-38

29

38

99

179

152

241

176

-2

-97

-139

-65

59

254

199

29

26

45

-24

106

198

103

178

117

177

193

-43

102

-47

-156

-46

-84

-125

-82

0

0

0

Increase (Decrease) in Accounts Payable

796

229

175

198

318

-59

71

304

193

320

309

55

67

104

157

-337

-913

-919

-1,325

-550

-115

-44

174

97

453

412

390

193

-317

-232

-37

-41

563

593

547

673

258

315

321

260

385

472

0

0

0

Deferred income

-

-

-

-

-

84

-467

-548

-693

-642

-600

-329

-225

-64

510

643

119

218

362

28

620

613

667

769

1,077

965

897

871

554

295

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Increase (Decrease) in Income Taxes Payable

1,016

907

51

-78

209

203

2,953

2,905

2,854

3,154

130

454

-91

-453

-66

-272

165

194

166

386

467

171

80

-34

-166

126

-4

-156

49

-50

-32

58

-86

-134

-69

-158

-200

-236

-185

-198

-119

58

0

0

0

Increase (Decrease) in Other Operating Assets and Liabilities, Net

-1,264

-702

-1,511

-741

-412

-634

-34

-59

145

227

-116

8

-122

-216

-479

-758

-758

-617

-105

177

272

-8

502

667

429

760

898

376

1,067

1,189

589

744

481

58

161

68

265

248

2,433

2,966

744

932

0

0

0

Net Cash Provided by (Used in) Operating Activities

10,571

8,067

8,458

7,181

6,155

5,940

4,628

5,062

5,589

5,275

5,601

5,292

4,147

3,058

2,499

1,619

1,251

2,105

1,793

2,172

3,157

3,148

3,986

4,136

4,590

3,545

2,971

6,502

6,126

6,941

7,673

4,787

4,746

4,840

4,867

4,552

4,508

4,491

4,240

4,330

4,077

4,065

0

0

0

Cash Flows From Investing Activities:
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale

3,992

3,809

3,390

3,587

3,148

2,379

3,555

5,195

5,677

6,398

5,431

4,298

4,212

4,809

4,019

3,780

3,046

2,794

3,773

4,965

5,227

4,095

3,066

1,475

1,640

1,815

2,026

2,831

3,251

4,890

6,536

6,852

7,392

5,960

4,393

4,161

3,502

3,197

3,086

2,746

2,448

2,075

0

0

0

Payments to Acquire Marketable Debt Securities

4,454

3,961

2,885

2,295

2,262

2,305

2,047

2,825

4,500

5,419

5,275

4,935

3,770

3,089

3,108

2,866

2,845

3,143

3,191

4,183

5,460

5,719

5,222

4,017

2,661

1,859

1,554

1,031

1,270

3,607

4,976

6,058

7,200

6,819

7,464

6,423

5,177

5,823

4,874

5,163

5,499

3,489

0

0

0

Payments to Acquire Property, Plant, and Equipment

818

836

875

909

916

951

915

953

1,003

1,055

1,172

1,251

1,264

1,215

1,129

1,022

926

820

726

599

544

526

535

552

540

537

512

525

540

548

507

454

415

367

358

363

370

424

495

575

658

730

0

0

0

Proceeds from Divestiture of Businesses, Net of Cash Divested

15,747

15,852

2,389

1,034

1,184

1,249

1,157

930

870

736

667

720

1,136

1,334

1,228

1,417

944

708

805

667

733

3,585

0

0

0

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

-

-

-

0

Payments to Acquire Businesses, Net of Cash Acquired

24,644

24,634

89

125

925

1,246

1,269

1,577

950

726

720

411

463

359

0

0

0

-

-

-

-

219

0

0

0

-

-

-

-

7,530

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Other investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net Cash Provided by (Used in) Investing Activities

-10,177

-9,770

1,930

1,292

229

-874

481

770

94

-66

-1,069

-1,579

-149

1,480

480

786

-900

-1,572

-237

-11

-242

1,216

550

-89

1,479

-572

20

-3,708

-3,539

-6,727

-6,509

-2,469

-3,027

-1,437

-4,411

-3,300

-2,730

-3,812

-2,360

-5,297

-5,973

-4,380

0

0

0

Cash Flows From Financing Activities:
Proceeds from (Repayments of) Short-term Debt

230

131

189

87

-272

-543

-1,088

-119

191

727

1,221

408

350

125

-401

-599

-222

-449

253

406

63

244

-245

282

-432

198

517

-151

570

49

-48

50

11

-1

-20

-24

2

-33

29

65

-45

-26

0

0

0

Issuance of long-term debt

-

-

-

-

-

-

-

-

-

1,488

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

1,489

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of Long-term Debt

8,006

9,256

1,256

1,256

1,255

5

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

676

0

0

0

-

-

-

-

2,108

2,108

109

133

78

0

0

0

-

-

-

0

-

-

-

-

Interest rate swap contract terminations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-99

-99

-74

-105

0

0

0

-

-

-

-

2

2

209

294

296

344

137

150

146

98

101

7

194

0

0

0

Issuance of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

290

289

290

288

310

321

466

564

549

592

574

463

633

680

707

601

406

365

223

252

0

0

0

-

-

-

-

Payments for Repurchase of Common Stock

7,381

7,300

300

0

153

320

569

789

636

2,469

2,220

2,000

2,000

231

0

0

0

-

-

-

-

-

-

-

-

433

925

1,923

2,361

2,403

2,273

1,696

1,412

1,221

1,082

796

724

576

0

0

0

-

-

-

-

Payments of Dividends

3,027

2,679

2,664

2,646

2,629

2,613

2,599

2,586

2,575

2,577

2,573

2,569

2,561

2,547

2,530

2,511

2,495

2,477

2,457

2,437

2,416

2,398

2,377

2,357

2,334

2,309

2,293

2,287

2,287

2,286

2,285

2,278

2,268

2,254

2,243

2,229

2,216

2,202

2,279

2,355

2,418

2,483

0

0

0

Proceeds from (Payments for) Other Financing Activities

2

-53

-39

-34

-33

-54

-48

-46

-42

-22

-7

-8

22

15

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from Mead Johnson initial public offering

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

782

0

0

0

Net Cash Provided by (Used in) Financing Activities

8,596

7,621

14,720

14,941

-4,342

-3,535

-4,309

-4,295

-4,286

-4,077

-3,330

-3,170

-2,716

-2,653

-3,407

-3,561

-3,892

-3,624

-2,496

-2,324

-1,927

-2,437

-1,495

-1,587

-2,216

-1,068

-2,737

-3,806

-3,541

-4,333

-4,129

-3,144

-2,801

-2,657

-3,567

-3,561

-3,549

-3,343

-685

-643

-858

-17

0

0

0

Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents

-79

-9

-27

-9

-49

-41

-36

-8

35

52

10

-7

-16

-33

-115

-109

-109

-95

0

0

0

-

-

-

17

25

14

32

2

-1

-3

-38

-16

-3

1

56

41

14

19

21

57

39

0

0

0

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect

8,911

5,909

25,081

23,405

1,993

1,490

764

1,529

1,432

1,184

1,212

536

1,266

1,852

-543

-1,265

-3,650

-3,186

-876

-83

1,069

1,985

3,080

2,461

3,870

1,930

268

-980

-952

-4,120

-2,968

-864

-1,098

743

-3,110

-2,253

-1,730

-2,650

1,214

-1,589

-2,697

-293

0

0

0